Sociodemographic characteristics and comorbidities of older adults associated with Primary Health Care quality.

Hepatitis C virus (HCV) infection is a significant public health concern, with substantial implications for morbidity and mortality worldwide. A key step in achieving the World Health Organization’s goal of eliminating hepatitis C by 2030 is to identify individuals at risk using robust screening methods to detect undiagnosed cases. However, many countries, including Argentina, face challenges in conducting effective hepatitis C screening and surveillance. While the global prevalence of hepatitis C virus infection is estimated to be around 2.5%, there are significant geographic variations in incidence and prevalence. HCV infection remains a major public health challenge in Argentina, being a leading cause of cirrhosis, hepatocellular carcinoma, liver transplantation, and liver-related mortality. Despite advances in treatment, a significant proportion of infected individuals remain undiagnosed and untreated, contributing to the ongoing burden of HCV-related complications. In Argentina, available data suggest that hepatitis C prevalence may range from 0.7% to 2% of the population. Furthermore, anti-HCV positivity has been associated with increased overall mortality.